Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Yong-Chen Lu

Concepts (182)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
14
2025
146
4.040
Why?
Receptors, Antigen, T-Cell
11
2025
52
3.000
Why?
Lymphocytes, Tumor-Infiltrating
18
2025
89
2.930
Why?
T-Lymphocytes
10
2025
320
2.480
Why?
Immunotherapy
7
2025
266
2.440
Why?
Immunotherapy, Adoptive
8
2019
163
2.250
Why?
Neoplasms
10
2024
1335
2.200
Why?
CD4-Positive T-Lymphocytes
5
2024
166
1.480
Why?
Cancer Vaccines
4
2021
79
1.280
Why?
High-Throughput Nucleotide Sequencing
3
2021
181
1.130
Why?
Mutation
12
2019
1338
0.870
Why?
Single-Cell Analysis
3
2022
72
0.690
Why?
CD8-Positive T-Lymphocytes
9
2025
145
0.680
Why?
Immune System
1
2020
41
0.620
Why?
Alcohol Oxidoreductases
1
2019
13
0.590
Why?
HLA-DP beta-Chains
2
2017
3
0.560
Why?
Neoplasm Proteins
2
2017
330
0.540
Why?
Urinary Bladder Neoplasms
1
2019
167
0.520
Why?
Genetic Therapy
2
2017
127
0.510
Why?
DNA-Binding Proteins
1
2019
423
0.480
Why?
Melanoma
3
2016
277
0.480
Why?
Proto-Oncogene Proteins p21(ras)
4
2019
69
0.420
Why?
Immunodominant Epitopes
2
2015
9
0.420
Why?
Humans
31
2025
53246
0.400
Why?
Cytokines
4
2019
627
0.390
Why?
Protein Phosphatase 1
1
2013
6
0.390
Why?
Animals
12
2024
13528
0.390
Why?
Phosphoprotein Phosphatases
1
2013
16
0.390
Why?
Lymphocyte Activation
5
2021
163
0.380
Why?
Proto-Oncogene Proteins c-rel
2
2010
5
0.380
Why?
Antibodies, Monoclonal
1
2016
477
0.360
Why?
Neoplasm Metastasis
3
2022
237
0.320
Why?
Colorectal Neoplasms
3
2019
302
0.320
Why?
CCAAT-Enhancer-Binding Protein-beta
1
2009
5
0.300
Why?
Toll-Like Receptors
1
2009
25
0.300
Why?
CCAAT-Enhancer-Binding Protein-delta
1
2009
23
0.290
Why?
Lipopolysaccharides
2
2022
203
0.290
Why?
Transcriptome
2
2022
368
0.280
Why?
Glioblastoma
2
2021
101
0.280
Why?
Toll-Like Receptor 4
1
2008
48
0.260
Why?
Signal Transduction
5
2019
1748
0.260
Why?
Adoptive Transfer
3
2018
29
0.240
Why?
Cells, Cultured
5
2021
1569
0.230
Why?
Gene Expression Profiling
2
2021
1112
0.220
Why?
Autoantigens
2
2015
46
0.220
Why?
T-Lymphocytes, Regulatory
2
2016
83
0.200
Why?
Gene Library
2
2014
40
0.200
Why?
Carcinoma, Hepatocellular
1
2025
213
0.190
Why?
Nephritis
1
2022
23
0.180
Why?
Receptors, Immunologic
1
2022
36
0.180
Why?
Clone Cells
2
2019
76
0.180
Why?
Middle Aged
9
2025
13422
0.180
Why?
Ureteral Obstruction
1
2022
62
0.170
Why?
Liver Neoplasms
1
2025
347
0.170
Why?
HLA-A Antigens
2
2019
11
0.170
Why?
Human papillomavirus 16
1
2021
44
0.170
Why?
Adaptor Proteins, Signal Transducing
2
2014
202
0.170
Why?
Tumor Suppressor Protein p53
2
2022
228
0.170
Why?
T-Cell Antigen Receptor Specificity
2
2017
4
0.160
Why?
Membrane Glycoproteins
1
2022
238
0.160
Why?
Papillomavirus Vaccines
1
2021
74
0.160
Why?
Interleukin-2
2
2017
69
0.150
Why?
Mucin-4
1
2019
1
0.150
Why?
Smad5 Protein
1
2019
2
0.150
Why?
Renal Insufficiency, Chronic
1
2022
205
0.140
Why?
Uterine Cervical Neoplasms
1
2021
301
0.140
Why?
Cell Differentiation
1
2021
681
0.140
Why?
Flow Cytometry
3
2016
400
0.130
Why?
Epitopes, T-Lymphocyte
2
2014
25
0.130
Why?
Administration, Intravenous
1
2017
73
0.130
Why?
Colonic Neoplasms
1
2019
162
0.130
Why?
Hematopoietic Stem Cell Transplantation
1
2022
610
0.130
Why?
Male
7
2025
27444
0.130
Why?
Membrane Proteins
1
2019
333
0.130
Why?
Aged
3
2025
10430
0.130
Why?
Exome
2
2014
54
0.120
Why?
Cell Line, Tumor
2
2017
1470
0.120
Why?
Gene Expression Regulation
2
2019
1003
0.120
Why?
CTLA-4 Antigen
1
2016
32
0.120
Why?
T-Lymphocytes, Helper-Inducer
1
2016
39
0.120
Why?
Programmed Cell Death 1 Receptor
1
2016
46
0.120
Why?
Transcription Factors
1
2019
571
0.120
Why?
Protein Binding
2
2014
670
0.110
Why?
Transplantation, Autologous
1
2017
488
0.110
Why?
Female
11
2025
28792
0.110
Why?
Gastrointestinal Neoplasms
1
2015
44
0.110
Why?
Treatment Outcome
4
2021
5597
0.110
Why?
Time Factors
2
2021
2992
0.110
Why?
Neutrophils
2
2014
153
0.110
Why?
Adult
7
2021
14541
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2019
868
0.110
Why?
Respiratory Burst
1
2014
4
0.110
Why?
Hepatitis B e Antigens
1
2014
3
0.110
Why?
Chemotaxis, Leukocyte
1
2014
12
0.110
Why?
Histocompatibility Antigens
1
2014
4
0.110
Why?
Epitope Mapping
1
2014
6
0.110
Why?
Bile Ducts, Intrahepatic
1
2014
13
0.100
Why?
Bile Duct Neoplasms
1
2014
29
0.100
Why?
Cholangiocarcinoma
1
2014
27
0.100
Why?
Th1 Cells
1
2014
50
0.100
Why?
Monocytes
1
2014
126
0.100
Why?
Alleles
1
2014
277
0.100
Why?
Amino Acid Sequence
1
2014
563
0.100
Why?
Peptides
1
2014
234
0.100
Why?
Gene Knockdown Techniques
1
2013
109
0.100
Why?
NF-kappa B
2
2011
327
0.090
Why?
Genes, T-Cell Receptor
2
2022
5
0.090
Why?
Base Sequence
1
2013
620
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
579
0.090
Why?
TNF Receptor-Associated Factor 2
1
2011
3
0.090
Why?
Molecular Sequence Data
1
2013
759
0.090
Why?
Autoimmunity
1
2011
34
0.090
Why?
Cell Line
1
2014
1016
0.090
Why?
Forkhead Transcription Factors
1
2012
120
0.090
Why?
Disease Progression
1
2014
880
0.080
Why?
Clinical Trials as Topic
1
2013
466
0.080
Why?
Lung Neoplasms
1
2016
645
0.080
Why?
Clonal Anergy
1
2010
13
0.080
Why?
Mice
4
2022
5982
0.080
Why?
Protein Kinase C
1
2010
68
0.080
Why?
Dendritic Cells
2
2022
133
0.080
Why?
Remission Induction
2
2021
222
0.080
Why?
Isoenzymes
1
2010
165
0.080
Why?
Interleukin-1 Receptor-Associated Kinases
1
2009
10
0.070
Why?
Myeloid Differentiation Factor 88
1
2009
32
0.070
Why?
Breast Neoplasms
1
2018
1223
0.070
Why?
Antineoplastic Agents
1
2017
1232
0.070
Why?
Transcriptional Activation
1
2009
128
0.070
Why?
Inflammation Mediators
1
2009
115
0.070
Why?
Antigen Presentation
2
2019
25
0.070
Why?
Cell Separation
2
2019
76
0.060
Why?
Complement C3a
1
2007
3
0.060
Why?
Complement C5a
1
2007
3
0.060
Why?
Macrophages
1
2009
380
0.060
Why?
Lymphocyte Count
2
2016
20
0.050
Why?
Tumor Microenvironment
1
2025
274
0.050
Why?
Th17 Cells
1
2022
26
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.040
Why?
Neoplasm Grading
1
2021
128
0.040
Why?
Gene Regulatory Networks
1
2022
112
0.040
Why?
Arginine
1
2022
178
0.040
Why?
Nitric Oxide
1
2022
233
0.040
Why?
Host-Pathogen Interactions
1
2021
135
0.040
Why?
Blotting, Western
2
2011
587
0.040
Why?
Lung
2
2016
481
0.040
Why?
Transduction, Genetic
1
2019
44
0.040
Why?
Immunologic Memory
1
2019
31
0.040
Why?
Neoplastic Cells, Circulating
1
2019
34
0.040
Why?
Coculture Techniques
1
2019
146
0.040
Why?
Transplantation Conditioning
1
2019
96
0.040
Why?
Lymphatic Metastasis
1
2019
211
0.030
Why?
Phenotype
2
2012
803
0.030
Why?
Molecular Targeted Therapy
1
2019
138
0.030
Why?
Cell Proliferation
1
2021
1031
0.030
Why?
HLA-DRB1 Chains
1
2017
6
0.030
Why?
Antigen-Presenting Cells
1
2017
22
0.030
Why?
Proteasome Endopeptidase Complex
1
2018
142
0.030
Why?
Pilot Projects
1
2019
727
0.030
Why?
Cross Reactions
1
2016
42
0.030
Why?
HLA-C Antigens
1
2015
5
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Inflammation
2
2011
653
0.030
Why?
Proto-Oncogene Proteins
1
2015
150
0.030
Why?
Clinical Trials, Phase II as Topic
1
2014
48
0.030
Why?
Chemokines
1
2014
78
0.030
Why?
Receptor, erbB-2
1
2014
79
0.030
Why?
Vaccination
1
2016
310
0.030
Why?
B-Lymphocytes
1
2014
178
0.020
Why?
Recombinant Proteins
1
2014
489
0.020
Why?
Dose-Response Relationship, Immunologic
1
2012
13
0.020
Why?
Whole-Body Irradiation
1
2012
129
0.020
Why?
Polymerase Chain Reaction
1
2011
452
0.020
Why?
Apoptosis
1
2014
1139
0.020
Why?
Mice, Knockout
1
2011
910
0.020
Why?
Mice, Transgenic
1
2010
561
0.020
Why?
Receptors, Chemokine
1
2007
12
0.020
Why?
Receptor, Anaphylatoxin C5a
1
2007
6
0.020
Why?
Complement Activation
1
2007
27
0.020
Why?
Cattle
1
2007
207
0.020
Why?
Actins
1
2007
114
0.020
Why?
Hematopoietic Stem Cells
1
2007
189
0.010
Why?
Fibroblasts
1
2007
363
0.010
Why?
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description